TP63 and COVID-19: BSCs from both COVID‐19 and control groups showed co‐expression of the airway progenitor markers KRT5 and P63 (Figure 1B) and demonstrated similar clonogenic potential of 30%–70% at Passage 5 (Figure 1C,D).